# Integrating responses to stimulant overdose among post-overdose programs

> **NIH ALLCDC R01** · BOSTON MEDICAL CENTER · 2022 · $724,692

## Abstract

Project Summary/Abstract
While fentanyl and fentanyl analogues are the main drivers opioid overdoses in the United States, cocaine and
other stimulants, like methamphetamine, are increasingly present in both opioid and non-opioid overdose
deaths. These stimulant-involved overdose deaths are now central to the “evolving overdose epidemic” or 4th
wave of the overdose crisis. As Black, Latinx, and Native people face inequities in the health care system and
lower access to substance use treatment, they are disproportionately affected by this stimulant-involved 4th
wave. In addition, among youth, there are now more polysubstance involved overdose deaths than opioid only
deaths. Post-overdose outreach programs have emerged as an important and growing response to overdose
deaths by providing timely follow-up to overdose survivors and are often collaboratively implemented by public
health and public safety teams. With the emerging recognition of the role of stimulants, like cocaine and
methamphetamine, overdose prevention programs warrant adaptation and enhancement to address stimulant
use, use disorders, and overdose risks. There is an opportunity to leverage these programs to develop and
introduce adaptations for stimulant use that will provide risk reduction education and stimulant-related
overdose prevention and linkage to treatment. Working within this infrastructure to partner with existing post-
overdose programs, we propose to develop a toolkit of strategies to reduce stimulant-involved deaths. Each of
these adaptations will be tailored to specifically engage people of color (Black, Latinx, and Native people) and
youth. Our specific aims are to: (1) develop and implement a toolkit of adaptations for post-overdose outreach
programs to address stimulant use and stimulant overdose overall and among people of color and youth; (2)
conduct a process evaluation of the adaptations to address stimulant use in programs; and (3) determine the
effectiveness of the toolkit of adaptations to: (a) increase contact with people who use stimulants, (b) reduce
stimulant risk behaviors, and (c) increase treatment access for stimulant use disorder overall and among
people of color and youth. Massachusetts provides a data-rich environment to ascertain the impact of post-
overdose outreach on stimulant overdose. Guided by principles of community-based participatory research, we
will integrate adaptive innovations to address stimulants learned from Massachusetts programs and use this
information to guide and inform the design and dissemination of stimulant overdose prevention in
communities across the country. The proposed research will address Objective 1, as described in the
Notice of Funding Opportunity.

## Key facts

- **NIH application ID:** 10491653
- **Project number:** 5R01CE003357-02
- **Recipient organization:** BOSTON MEDICAL CENTER
- **Principal Investigator:** Sarah M Bagley
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** ALLCDC
- **Fiscal year:** 2022
- **Award amount:** $724,692
- **Award type:** 5
- **Project period:** 2021-09-30 → 2024-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10491653

## Citation

> US National Institutes of Health, RePORTER application 10491653, Integrating responses to stimulant overdose among post-overdose programs (5R01CE003357-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10491653. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*